ArticleGut pathogens2026
Demographic characteristics and associated conditions in enteropathogenic Escherichia coli positive patients.
Article in Gut pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMany studies have examined the epidemiology and risk factors of Enteropathogenic Escherichia coli (EPEC); however, few have focused on the adult population. This study aimed to determine if EPEC was associated with certain patient populations or characteristics. We reviewed 792 hospitalized adults and children with symptomatic diarrhea who tested positive for EPEC on the BioFire Gastrointestinal (GI) Pathogen Panel and compared with symptomatic patients with no targets detected on the same panel as controls.
resultsIn the adult group the EPEC positive actual length of stay (LOS) was 13.5 days CI 95% [4.6,22.2] vs. 9.3 days CI 95% [7.9,10.5] (p = 0.14) for the control group, while in the pediatric population, both expected and actual LOS were actually longer in the EPEC negative patients than the EPEC positive patients (p ≤ 0.01 for both). In adults, 31.4% of EPEC positive patients had a past medical history of autoimmune disease, compared to 19.2% (p = 0.03) in the control group, after controlling for multiple variable testing.
conclusionTo our knowledge, this association between EPEC and autoimmune disease has not been previously reported and could be mediated by gut dysbiosis, suggesting avenues for follow up studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.